Developing the Cell|Based Therapies of the Future

Developing the Cell-Based Therapies of the Future - InventUM

Although still experimental, stem cell-based therapies are part of a major shift in the paradigm that governs therapeutic development — away ...

Engineering the next generation of cell-based therapeutics - Nature

Future developments should include developing human-derived components, developing larger capacity vectors to accommodate larger, more ...

Harnessing the power of cell therapy - AstraZeneca

Looking to the future, we are working to engineer cell therapies made from healthy donor blood cells. Our goal is to develop 'off-the-shelf' allogeneic cell ...

Emerging Technologies and Innovation in Manufacturing ... - NCBI

With the growing use of CRISPR-Cas9, the regenerative medicine field is likely to see an increased development of cell-based gene therapies, ...

Looking to the Future of Cell Therapy - Bristol Myers Squibb

“Cell therapy as a field can move quickly from first-in-human to registration studies, so it's particularly crucial to be able to analyze data ...

Developing CAR-T Cell Therapies for the Future

Despite slow growth over recent years, the CAR-T cell therapy space is expected to see considerable advancements in the near future.

Exploring the Future of Cell Therapy Research - LevitasBio

Despite its potential, the field faces research, development, and manufacturing challenges requiring further advancements. Cell-based assays are ...

Challenges and Solutions in Cell Therapy Development

To date, 27 cell therapies have been approved by the United States Food and Drug Administration (FDA) for the treatment of multiple indications, ...

Strengthening Pathways for Cell and Gene Therapies - IQVIA

Significant uncertainty still exists about the future trajectory and sustainability of the cell and gene therapy sector, with a range of future ...

Cell Therapy - Astellas Pharma Inc.

Cell-based therapeutics have tremendous potential ... We are working on integrating cell science and genetic science to develop the cell therapies of the future.

The Evolution and Future of Cell & Gene Therapy | Deloitte US

Cell and gene therapies (CGT) hold the promise of treating or even curing some cancers and rare diseases.

Current state of stem cell-based therapies: an overview - PMC

Cell-based therapy as a modality of regenerative medicine is considered one of the most promising disciplines in the fields of modern science & medicine. Such ...

Cell therapy in cancer | CAR-T cell therapy - AstraZeneca

Developing cell-based therapies to put cancer cures within reach · ORIGINALLY PUBLISHED: 23 December 2021 · Written by: · Gordon Moody · Mark ...

Development of strategies to improve cell therapy product - FDA

Cell-based therapies show great promise for repairing, replacing, restoring, or regenerating damaged cells, tissues and organs. Researchers are working to ...

Optimizing for the future: streamlining the production of T cell-based ...

The field of cell and gene therapy is progressing rapidly, but significant manufacturing challenges persist. Key concerns include delivering ...

Developmental and stem cell biology's bright future

Emerging advances in developmental biology are unlocking ways to transform human induced pluripotent stem cells (hiPSCs) into multicellular ...

What's the future of cell therapy at BMS? - Bristol Myers Squibb

Cell therapies are arguably the most personalized form of cancer treatment available today. “CAR” stands for chimeric antigen receptors, and the ...

New Frontiers of Cell Therapy - Genentech

“The use of engineered cells is the future of medicine, and developing off-the-shelf treatments using iPSCs represents the next step in cell ...

Past, Present, and Future of Cellular Immunotherapy - NIH VideoCast

This symposium will discuss the development of cell therapy for the treatment of human cancer, from early studies to the current state of ...

The future of engineered immune cell therapies - Science

Immune cells are being engineered to recognize and respond to disease states, acting as a “living drug” when transferred into patients.